Table 2.
Response to topical steroid therapy in patients with AAI and DAA.
| Therapy | n (%) | Stability | Improvement | Remission | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| T4 | T8 | T12 | T4 | T8 | T12 | T4 | T8 | T12 | ||
| AAI | ||||||||||
| Clobetasol 0.05% cream | 69 (64.49) | 17 (24.64) | 6 (8.69) | 5 (7.24) | 52 (75.36) | 34 (49.27) | 16 (23.19) | 0 (0) | 29 (42.03) | 48 (69.56) |
| Clobetasol 0.05% foam | 38 (35.51) | 11 (28.95) | 5 (13.16) | 3 (7.89) | 27 (71.05) | 13 (34.21) | 9 (23.68) | 0 (0) | 20 (52.63) | 26 (68.42) |
| DAA | ||||||||||
| Clobetasol 0.05% cream | 22 (88) | 5 (22.72) | 2 (9.09) | 1 (4.54) | 17 (77.27) | 5 (22.73) | 0 (0) | 0 (0) | 15 (68.18) | 21 (95.45) |
| Clobetasol 0.05% cream | 3 (12) | 1 (33.33) | 0 (0) | 0 (0) | 2 (66.66) | 1 (33.33) | 1 (33.33) | 0 (0) | 2 (66.66) | 2 (66.66) |
AAI = alopecia areata incognita; DAA = diffuse alopecia areata.